Minuscule risk, large benefits for osteoporosis drugs
Millions of women with low bone density take bisphosphonates, a class of drugs used to prevent osteoporosis. But a new analysis by the FDA may lead some of these women, and their doctors, to rethink their treatment plans: The review suggests that certain women may be better off taking these drugs for a shorter period of time, instead of on a long-term basis and some should stop taking them altogether.
